Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 5 clinical trials
Primary Prophylaxis for Spontaneous Bacterial Peritonitis

treatment. Treatment of SIBO would reduce the risk of spontaneous bacterial peritonitis and other liver-related morbidities. We aim to treat a cohort of patients with severe liver disease and concomitant

  • 0 views
  • 10 Mar, 2021
  • 1 location
Intralipid Versus SMOFlipid in HPN Patients

This study will randomize all patients who are new to the Mayo Clinic HPN team to either standard lipid emulsion (Intralipid) or SMOFLipid.

lipid emulsion
smoflipid
  • 1 views
  • 02 Jul, 2022
  • 1 location
A Prospective Cohort Study of Metabolic Associated Fatty Liver Disease in China

but no metabolic risk, who thus do not meet the diagnostic criteria of MAFLD. Besides, there are patients with both MAFLD and other liver diseases. The clinical features and the management of these

  • 4 views
  • 18 Feb, 2021
  • 1 location
Deep Liver Phenotyping and Immunology Study (DELPHI)

to those of patients with other diseases of the liver who are at risk of developing cancer in the future. The investigators aim to detect changes in the liver, blood, urine and/or bile of

cancer
  • 0 views
  • 21 Apr, 2022
  • 1 location
18F-FAPI PET in the Diagnosis of Liver Fibrosis

It is an open label observation clinical trial, all participants are chronic liver disease. The investigators deem to make a novel evaluate criteria to hepatic fibrosis. The point of the clinical trial is to evaluate the novel biomaker 18F-FAPI-04 by PET-CT scan in the evaluation of the hepatic fibrosis.

hepatic fibrosis
biopsy of liver
fibrosis
liver disease
hepatitis
  • 0 views
  • 12 Mar, 2022
  • 1 location